Month: July 2021

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2021   (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)    Market : NYSE Euronext Paris ISIN Code: FR 0010417345DateTotal number of shares Total number of voting rights06/30/2021 55,011,687Total gross of voting rights: 55,011,687Total net* of voting rights: 54,933,812* Total net = total number of voting rights attached to shares – shares without voting rights  AttachmentPDF Version

Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the completion of its previously announced underwritten public offering of 2,500,000 shares of its common stock, $0.001 par value per share, at a price to the public of $4.00 per share. The gross proceeds to BioSig from this offering were $10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by BioSig. Laidlaw & Company (UK) Ltd. acted as sole book-running manager for the offering. BioSig intends to use the net proceeds from the offering for the...

PEARL RIVER, N.Y., July 07, 2021 (GLOBE NEWSWIRE) — Sterling Bancorp (NYSE: STL), the parent company of Sterling National Bank, today announced that it plans to release results for the second quarter ended June 30, 2021 after the market close on Wednesday, July 21, 2021. Jack Kopnisky, President and CEO of Sterling Bancorp, will host a teleconference and webcast on Thursday, July 22, 2021 at 8:00 AM Eastern Time to discuss the Company’s results. Analysts, investors and interested parties are invited to listen to the webcast and view accompanying slides on the Company’s website at www.sterlingbancorp.com or by dialing (800) 263-0877, Conference ID 3008771. The webcast will also be available at: https://event.webcasts.com/starthere.jsp?ei=1476375&tp_key=8246f99b4d. A replay of the teleconference can be accessed through the Company’s...

Las Vegas, NV, July 07, 2021 (GLOBE NEWSWIRE) — (OTC PINK: BOXS) (“The Company”), is providing this update from its CEO, Andrew Boutsikakis. Dear Shareholders, I wanted to take this opportunity to thank you for your vote of confidence in our company as evidenced by your ownership of our common stock.  I assumed the role of CEO of in February 2020. Since taking over, I, along with our independent Board of Directors, have been working diligently to restructure debt, meet our capital obligations and fully review our business model, while meeting our public company reporting obligations. We have made great strides in what has been an unprecedented 2020.  The pandemic forced me to look at the business model, debt structure and capital requirements and make some very difficult choices as our points of distribution shut down,...

San Diego, California, July 07, 2021 (GLOBE NEWSWIRE) — HUMBL, Inc. (OTC Markets: HMBL) announced today that CEO Brian Foote has agreed to retire 9,350 shares of Series B Preferred Stock that he owns, which is the equivalent of 93,500,000 shares of common stock. The market value of these shares based on the prior trading day’s closing price at the time the request was submitted was over $100,000,000 (USD). Mr. Foote previously retired 551,669,335 pre-split common shares from the float in November 2020, also at his own personal cost. The purpose of this share retirement is to reduce the overall HUMBL share count and protect HUMBL investors from dilution as the company pursues its brand partnerships, top line revenue and market share acquisition strategies. The retired shares are sufficient to cover the shares that have been or will...

MOLINE, Ill., July 07, 2021 (GLOBE NEWSWIRE) — QCR Holdings, Inc. (NASDAQ: QCRH) announced today that its second quarter ended June 30, 2021 financial results will be released after the market closes on Monday, July 26, 2021. The Company will host a conference call and webcast the next day, Tuesday, July 27, 2021 at 10:00 a.m. Central Time to discuss the results. Shareholders, analysts, and other interested parties are invited to join. Teleconference:  Dial-in information for the call is 888-346-9286 (international 412-317-5253). Participants should request to join the QCR Holdings, Inc. call. The event will be archived and available for replay through August 10, 2021. The replay access information is 877-344-7529 (international 412-317-0088); access code 10158303. Webcast:  A webcast of the teleconference can be accessed at the...

SANTA ANA, Calif., July 07, 2021 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ:TTMI) will host a conference call on Wednesday, July 28th, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss its second quarter fiscal year 2021 performance. Telephone access is available by dialing 800-367-2403 or international 334-777-6978 (ID 3384553). The conference call will also be simulcast on the company’s website, www.ttm.com, and will remain accessible for one week following the live event. TTM Technologies will release its second quarter fiscal year 2021 financial results after the market closes on Wednesday, July 28, 2021. About TTMTTM Technologies, Inc. is a leading global printed circuit board manufacturer, focusing on quick-turn and volume production of technologically advanced PCBs and backplane assemblies as well as a global...

SAN FRANCISCO and SAN DIEGO, July 07, 2021 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, today announced that its Chief Executive Officer Nima Farzan will participate in the William Blair Biotech Focus Conference 2021, being held virtually from July 14-15, 2021. Event: William Blair Biotech Focus Conference 2021Panel: “Next Generation Small Molecules in Oncology”Location: VirtualDate: Thursday, July 15, 2021Time: 9:00 AM ET/ 6:00 AM PT Members of the Kinnate management team will also host investor meetings during the conference. A live webcast of the William Blair panel discussion will be available in the Investors and Media section of the Kinnate website...

IRVINE, Calif., July 07, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced Bobak Azamian, M.D., Ph.D., President and Chief Executive Officer of Tarsus, will provide a brief corporate update at the Ladenburg Thalmann 2021 Virtual Healthcare Conference. Presentation DetailsDate: Wednesday, July 14Time: 1:30 PM ET/10:30 AM PTWebcast: https://wsw.com/webcast/ladenburg7/tars/2438302 The live webcast will be hosted on ir.tarsusrx.com and available for replay for a period of 90 days. About Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that applies...